old老太做受,欧美成熟美妇乱,最近韩国高清免费观看视频大全 ,大胆人体艺术视频

Like2291 2019-07-25 11:14 IP:重慶
1、https://www.sciencedirect.com/science/article/pii/S0022354917307177 2、Justus Liebigs Annalen der Chemie, 1907, vol. 351, p. 319 3、Efficacy and tolerability of amlodipine in patients with stable angina pectoris: an open-label, multicenter trial Volume 59, Issue 4, April 1998, Pages 215-222 4、Efficacy and safety of perindopril arginine + amlodipine in hypertension Journal of the American Society of Hypertension Volume 9, Issue 4, April 2015, Pages 266-274 5、Sprifermin shows cartilage-protective effects in knee OA 6、Justus Liebigs Annalen der Chemie, 1907, vol. 351, p. 319 7、Quantitation of cytokine levels in skin graft donor site wound fluid. Grayson LS1, Hansbrough JF, Zapata-Sirvent RL, Dore CA, Morgan JL, Nicolson MA. 8、Preparation of tadalafil analogues as antiparasitic agents 9、https://academic.oup.com/mmy/article-abstract/57/2/181/4909416?redirectedFrom=fulltext 10、https://jamanetwork.com/journals/jamadermatology/article-abstract/557354 11、Bioequivalence assessment of Fumatifen? tablet to Zaditen? tablet (ketotifen fumarate 1 mg) by liquid chromatography tandem mass spectrometry 12、Pharmacokinetics of ketotifen after oral administration to healthy male subjects 13、Optimal medical management of peripheral arterial disease. Rice TW, Lumsden AB. Vasc Endovascular Surg. 2006 Aug-Sep;40(4):312-27. Review. 14、Treatment of small hepatocellular carcinomas 15、CIMETIDINE, THE IMMUNE SYSTEM, AND CANCER 16、Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial 17、https://www.karger.com/Article/Abstract/236401 18、Reaction of enamines and mediated anodic oxidation of carbohydrates with the 2,2,6,6-tetramethylpiperidine-1-oxoammonium ion (TEMPO+) Electrochimica Acta, Volume 50, Issues 25–26, 5 September 2005, Pages 4956-4972 19、An improved HPLC method for determination of nifuratel in human plasma and its application to pharmacokinetics studies XL   [更多]
懸賞:
懸賞
¥350.00
已托管
載入中...
Personal 2019-07-17 14:22 IP:重慶
根據已知省份、城市的醫院銷售數據樣本,根據樣本數據如何計算醫院銷售數據在全國的銷售量、銷售額? 放大規則提供相關原理,思路,計算中所需要的樣本變量(字段,如:如“某藥品的藥品銷售額”與“樣本對于省份”,“樣本城市數量”、“樣本醫院數量”、“樣本醫院等級比例”等的關系),以及相關規格參數以及參數計算的方式,具體細節可私下溝通。   [更多]
懸賞:
懸賞
¥1000.00
已托管
載入中...
quincy 2019-06-25 12:41 IP:上海
求歐洲藥典全套9.2英文版   [更多]
懸賞:
懸賞
¥50.00
已托管
載入中...
wx_仔仔 2019-06-04 15:04 IP:重慶
藥物研發中心全套質量管理體系文件,越詳細越好,價格可談!   [更多]
懸賞:
懸賞
¥50.00
已托管
載入中...
Like2291 2019-04-29 09:15 IP:重慶
1.Nihon Yakurigaku Zasshi. 2013 Jul;142(1):39-46. doi: 10.1254/fpj.142.39. Pharmacological and clinical properties of AIMIX combination tablets LD&HD, fixed-dose combination of irbesartan and amlodipine besilate. 2.Am J Cardiovasc Drugs. 2013 Apr;13(2):141-50. doi: 10.1007/s40256-013-0014-7. Irbesartan/amlodipine: a review of its use in adult patients with essential hypertension not adequately controlled with monotherapy. 3.Clin Ther. 2012 Aug;34(8):1705-19. doi: 10.1016/j.clinthera.2012.06.026. Epub 2012 Jul 30. I-COMBINE study: assessment of efficacy and safety profile of irbesartan/amlodipine fixed-dose combination therapy compared with amlodipine monotherapy in hypertensive patients uncontrolled with amlodipine 5 mg monotherapy: a multicenter, phase III, prospective, randomized, open-label with blinded-end point evaluation study. 4.Clin Ther. 2012 Aug;34(8):1720-34.e3. doi: 10.1016/j.clinthera.2012.07.001. Epub 2012 Jul 30. I-ADD study: assessment of efficacy and safety profile of irbesartan/amlodipine fixed-dose combination therapy compared with irbesartan monotherapy in hypertensive patients uncontrolled with irbesartan 150 mg monotherapy: a multicenter, phase III, prospective, randomized, open-label with blinded-end point evaluation study. 5.Am J Cardiovasc Drugs. 2013 Apr;13(2):141-50. doi: 10.1007/s40256-013-0014-7. Irbesartan/amlodipine: a review of its use in adult patients with essential hypertension not adequately controlled with monotherapy. 6J Cardiol. 2019 Mar 20. pii: S0914-5087(19)30053-X. doi: 10.1016/j.jjcc.2019.03.001. [Epub ahead of print] Arginine vasopressin antagonism in heart failure: Current status and possible new directions. Goldsmith SR1. 7.Metabolism of Peptide Drugs and Strategies to Improve their Metabolic Stability 8.Expert Rev Neurother. 2017 Jan;17(1):59-75. Epub 2016 Oct 20. Modulation of GLP-1 signaling as a novel therapeutic approach in the treatment of Alzheimer's disease pathology. Tramutola A1, Arena A1,   [更多]
懸賞:
懸賞
¥260.00
已托管
載入中...
wx_我01 2019-04-12 16:55 IP:保定
公司需求幾篇藥品文獻資料。臨床應用數據。具體產品私信我找到一篇50元   [更多]
懸賞:
懸賞
¥50.00
已托管
載入中...
a15605712008 2019-04-10 10:56 IP:杭州
光子修復凝膠一類醫療器械備案全套資料   [更多]
懸賞:
懸賞
¥50.00
已托管
載入中...
yangliao 2019-01-30 09:19 IP:重慶
求DOF期刊2018年10-12期文獻   [更多]
懸賞:
懸賞
¥280.00
已托管
載入中...
小餅干21 2018-12-29 11:44 IP:重慶
1. Miller J. Ogidigben, Teh-Ching Chu and David E. Potter. Naphazoline-induced neuroendocrine changes Increases in ANP and cGMP levels 2. Robert J. Dockhorn and Thomas G. Duckett. Comparison of Naphcon-A and Its components 3. Mark B, Abelson MD, Salim I, et al. Tolerance and absence of rebound vasodilation following topical ocular decongestant usage 4. Ogidigben MJ, Chu TC, Potter DE. Naphazoline-induced suppression of aqueous humor pressure and flowinvolvement of central and peripheral alpha(2) I(1) receptors 5. The efficacy of long-term treatment with Tolvaptan to prolong the time until dialysis initiation in patients with chronic kidney disease and heart failure 6. Renoprotective effects of tolvaptan in hypertensive heart failure rats depend on renal decongestion 7. Tolvaptan Efficiently Reduces Intracellular Fluid Working Toward a Potential Treatment Option for Cellular Edema 8. Analysis of tolvaptan non-responders and outcomes of tolvaptan treatment of ascites 9. Tolvaptan in Japanese patients with later-stage autosomal dominant polycystic kidney disease 10. Safety and Effectiveness of Tolvaptan Administration after Total Arch Replacement 11. Nephrol Dial Transplant. 2018 Oct 12. doi 10.1093ndtgfy297. [Epub ahead of print] 12. Nephrol Dial Transplant. 2018 Oct 11. doi 10.1093ndtgfy298. [Epub ahead of print] 13. Development and validation of RP-HPLC method for simultaneous estimation of Ofloxacin and Ornidazole inpresence of Ornidazole Impurity in combined pharmaceutical dosage form 14. Stability-indicating methods for the determination of Ornidazole in the presence of its degradate according to ICH guidelines 15. A sensitive HPLC method of determination of 2-methyl 5-nitro imidazole & reaction mass of intermediates of ornidazole in ornidazole bulk manufacturing 16. Development and validation of a reversed-phase HPLC method for the analysis of ornidazole in pharmaceutical dosage forms 17. On the hydrolytic behavior of tinidazole, metronidazole,   [更多]
懸賞:
懸賞
¥110.00
已托管
載入中...
小餅干21 2018-12-28 10:05 IP:重慶
1.Bulletin of the Chemical Society of Japan, Volume 26, Pages 119-122, Journal, 1953 2.Dalton Transactions 2017,vol. 46, # 5, p. 1510 - 1519 3.Design and evaluation of ophthalmic pharmaceutical products. In Banker GS, Rhodes CT, eds. Modern Pharmaceutics, 4th edn. New York Marcel Dekker, 2002 415-478 4.Ixabepilone plus capecitabine with capecitabine alone for metastatic breast cancer 5.Journal of Photochemistry and Photobiology, B Biology, Volume 97, Issue 1, Pages 18-21, Journal, 2009 6.Journal of Photochemistry and Photobiology, B Biology, Volume 115, Pages 51-57, Journal; Online Computer File, 2012 7.Nair AD, Lach JL. The kinetics of degradation of chlorobutanol. J Am Pharm Assoc (Sci) 1959; 48 390-395. 8.Phase II study of the halichondrin B analog eribulin mesylate in patients with locally advanced or metastatic breast cancer previously treated with an anthracycline, a taxane, and capecitabine 9.Plasma?renin?activity-guided strategy for the management of hypertension. 10.Stability of chlorobutanol in aqueous solutions Journal of the American Pharmaceutical Association (1961), Volume 6, Issue 7, July 1966, Pages 372-373 11.Talanta, Volume 146, Pages 732-736, Journal; Online Computer File, 2016   [更多]
懸賞:
懸賞
¥55.00
已托管
載入中...
發布需求,坐等藥智客上門
  • 安全可靠,先驗收再正式付款
  • 性價比超高,節省一半費用
  • 80%的需求得到了圓滿解決
立即發布需求

推薦任務

主站蜘蛛池模板: 衡东县| 砚山县| 新和县| 甘洛县| 武定县| 资中县| 嘉义市| 阳西县| 洪雅县| 大关县| 江山市| 迁安市| 福鼎市| 延长县| 仁寿县| 龙游县| 淮滨县| 威信县| 台安县| 柘荣县| 涞水县| 汉寿县| 托克托县| 柳江县| 兴安县| 姚安县| 嵊州市| 石屏县| 阳谷县| 达拉特旗| 罗定市| 景德镇市| 舞钢市| 桃园市| 琼中| 潢川县| 梧州市| 海原县| 龙江县| 昂仁县| 南丹县|